Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13Breast Neoplasms 5Prostatic Neoplasms 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Neoplasms 3Neoplasm Metastasis 3Stomatitis 2Stomach Neoplasms 2Leukemia, Myeloid, Acute 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Trauma, Nervous System 1Thromboembolism 1Small Cell Lung Carcinoma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1Lipoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Intracranial Hemorrhages 1

Interventions

Prednisone 103enzalutamide 76Docetaxel 72Abiraterone Acetate 68Leuprolide 47acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 45abiraterone 39apalutamide 29Prednisolone 27bicalutamide 26Zoledronic Acid 24radium Ra 223 dichloride 22pembrolizumab 22darolutamide 22Goserelin 22Triptorelin Pamoate 17cabazitaxel 16Androgen Antagonists 15sipuleucel-T 13luprolide acetate gel depot 12Injections 12Dexamethasone 12olaparib 11gallium 68 PSMA-11 10Mitoxantrone 10Pluvicto 9Ipilimumab 9Dutasteride 9Cyclophosphamide 9relugolix 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Prostatic Neoplasms × Saline Solution × Clear all
NCT03834493 2025-07-18

KEYNOTE-641

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
1,244 enrolled 21 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Completed
1,030 enrolled 24 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

Bayer

Phase 3 Completed
806 enrolled 32 charts
Genitourinary

Prostatic Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Terminated
81 enrolled 19 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡